Director, GCP Quality Assurance

Marea Therapeutics•South San Francisco, CA
•$205,000 - $235,000

About The Position

Marea Therapeutics is seeking a motivated Director, Good Clinical Practice (GCP) Quality Assurance to build and lead the GCP quality program supporting its clinical portfolio. The role is responsible for the company’s GCP quality management system, risk-based clinical audit program, and GCP inspection readiness as programs advance to Phase 3 development. This is a hands-on, build-oriented role requiring both strategic thinking and direct execution. The Director will plan and conduct audits, author procedures, and partner with clinical study teams and internal and external cross-functional teams. The position reports to the Executive Director, Regulatory Affairs, and will contribute to the future development and growth of the GCP Quality function. It carries independent quality judgment and direct escalation authority for material GCP compliance matters.

Requirements

  • 12+ years of pharmaceutical or biotech industry experience, including at least 8 years in GCP/Clinical Quality Assurance.
  • Bachelor’s degree in life science, nursing, pharmacy, or a related field.
  • At least 5 years of experience personally planning and conducting GCP audits of investigator sites, CROs, and clinical vendors.
  • Sponsor-side experience qualifying and overseeing CROs and clinical vendors, including qualification audits, quality agreements, and risk-based ongoing oversight.
  • Experience preparing for, hosting, and supporting health authority GCP inspections, including FDA BIMO, EMA, and MHRA.
  • Experience supporting global late-stage, pivotal, or registrational clinical trials.
  • Experience building or maturing a GCP quality system in a small or emerging company.
  • Strong working knowledge of ICH E6(R3), ICH E8(R1), 21 CFR Parts 11, 50, 54, 56, and 312, EU Clinical Trials Regulation 536/2014 and CTIS, and applicable global GCP requirements.
  • Experience with eTMF and electronic QMS platforms, such as Veeva Vault, including familiarity with 21 CFR Part 11 and EudraLex Annex 11 expectations for GCP computerized systems.
  • Ability to assess compliance risk, interpret regulations and guidance, and implement practical, phase-appropriate solutions.
  • Ability to collaborate and influence cross-functionally, build strong internal and external relationships, and maintain independent quality judgment.
  • Ability to lead and build high-functioning teams.
  • Experience selecting and managing external quality resources, such as contract auditors and GCP QA consultants, including scoping, budget, and deliverable quality.
  • Strong oral and written communication skills, including the ability to translate complex regulatory requirements into clear guidance and influence at all levels of the organization.
  • Exceptional time and project management skills, including the ability to execute plans under pressure in a small, fast-paced environment with tight deadlines.
  • Comfort with ambiguity and a demonstrated hands-on approach.

Nice To Haves

  • Advanced degree in a life science, nursing, pharmacy, or related field.
  • Experience supporting a BLA/NDA/MAA submission.
  • Professional certification such as RQAP-GCP, ASQ CQA, CCRA, or RAC.
  • Late-stage development through filing experience within a small company environment.

Responsibilities

  • Establish, implement, and continuously mature Marea’s GCP quality management system, ensuring processes are phase-appropriate, compliant, and scalable as the clinical portfolio advances.
  • Own the risk-based GCP audit program, including annual and study-specific audit plans; plan and personally conduct audits of investigator sites, CROs, central labs, and specialty clinical vendors; and manage contract auditor selection, workflow, and deliverable quality.
  • Lead GCP inspection readiness across programs, including mock inspections, subject matter expert preparation, and the front-room/back-room operating model.
  • Drive pre-submission GCP inspection readiness for marketing applications, including for-cause audits of high-enrolling and high-risk investigator sites, Trial Master File completeness and traceability, and reconstruction readiness of the clinical submission dataset.
  • Lead the development, review, approval, implementation, and lifecycle management of GCP SOPs and controlled documents, partnering with Clinical Development and Clinical Operations on fit-for-purpose procedures.
  • Lead risk-based qualification and ongoing oversight of CROs and clinical vendors, including qualification audits, quality agreements, performance monitoring, and vendor governance; serve as the sponsor Quality counterpart to CRO and vendor quality organizations.
  • Oversee GCP quality events, protocol deviations, investigations, root cause analysis, CAPAs, and effectiveness verification.
  • Serve as the day-to-day Quality partner to clinical study teams from protocol review through clinical study report, and provide quality review of protocols, informed consent forms, monitoring plans, data management plans, TMF plans, clinical study reports, Investigator’s Brochures, and clinical sections of regulatory submissions.
  • Lead or oversee investigations of significant non-compliance, including suspected serious breaches under EU CTR Article 52, data integrity concerns, and scientific misconduct; support notification decisions with Regulatory Affairs and Legal.
  • Develop and deliver GCP training and maintain training curricula and matrices for internal staff and external clinical-trial partners.
  • Compile, trend, and report GCP quality metrics and vendor quality performance to leadership, and drive periodic quality management review.
  • Monitor evolving GCP regulations, guidance, and inspection trends, and translate requirements into practical guidance for study teams and company leadership.
© 2026 Teal Labs, Inc
Privacy PolicyTerms of Service